Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed... see more

NDAQ:LMNL - Post Discussion

Liminal BioSciences Inc. > The real questions
View:
Post by aussyspitz on Feb 24, 2020 10:45am

The real questions

1. Do you believe in the science?

2. Do you trust that Liminal and Thomvest can succesfully bring this to market and actually increase its value for shareholders given there 25+ year involvement?

3. There are always 3 possibilities when you invest stock goes up, stock stays flat, stock goes down. Is it not pure folly to only consider the possibility of the first without at least considering the possibility and or consequences of the second or third?

4. At today's share price of $12.06 investors averaged in at the offering price of $15.21 are now down 20.7%. Do you feel that is an acceptable return of your investment over the last 10 months under new ownership?

5. What impact do you think the Lawsuit will have on the share price is it likely to be postive or negative?

6. Have Prometic, Liminal and Thomvest executives, directors, management and employees not made money over the last 25 years? What about shareholders?
Comment by realstocky on Feb 24, 2020 11:26am
This post has been removed in accordance with Community Policy
Comment by Arrakis37 on Feb 24, 2020 12:48pm
What make sense however is that everyone left. Or if you want, you can believe that a few thousand shares per day is a significant volume...  We're many who have lost a lot in this daylight robbery.  We will not going back, there's so many other opportinuties than this fraud.  Anyway, even if they succeed, the company will go private.     So, continue ...more  
Comment by realstocky on Feb 24, 2020 1:49pm
This post has been removed in accordance with Community Policy
Comment by Arrakis37 on Feb 24, 2020 3:03pm
Incredible.   First : It's my second post in a year.   Second : You're not only a paid pumper but a really bad one (or a robot).  There's PLENTY of shares available, people are just NOT INTERRESTED ANYMORE.  Where are those people ?  they just moved on.  Do you really believe in this company ? Have you looked on the charts recently ?  It ...more  
Comment by Newcamo on Feb 24, 2020 3:14pm
This post has been removed in accordance with Community Policy
Comment by GunnerG on Feb 24, 2020 3:05pm
Yes realstups, the date of the financial transaction is less than a year. Pierre has been gone since Dec 18, 2018.  TV was in control even before that time. Stups, why can't you, Newcamo and Pando not spell the product name correctly?  One person, many ID's.  Your so lame.  RYPLAZIM not riplazym as the three ID's post all the time.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities